Cargando…
Pralatrexate for refractory mycosis fungoides in two Japanese patients
Pralatrexate has been approved for the treatment of relapsed/refractory peripheral T cell lymphomas. Studies in the U.S. also support the clinical efficacy of pralatrexate to treat advanced‐stage cutaneous T‐cell lymphomas, but outcomes in Japanese patients have not yet been reported. We herein desc...
Autores principales: | Teraishi, Mika, Oguro, Tokuko, Kusume, Ema, Kobashi, Haruka, Sano, Hozumi, Fujioka, Ai, Yamamoto, Mayuko, Nakajima, Hideki, Sano, Shigetoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248132/ https://www.ncbi.nlm.nih.gov/pubmed/33454985 http://dx.doi.org/10.1111/1346-8138.15761 |
Ejemplares similares
-
Mycosis Fungoides with Photosensitivity Mimicking Chronic Actinic Dermatitis
por: Sinha, Anwita, et al.
Publicado: (2020) -
Nivolumab in two cases of refractory mycosis fungoides erythroderma
por: Chmielowska, Ewa
Publicado: (2021) -
Syringotropic and folliculotropic mycosis fungoides with mycosis fungoides–associated vasculopathic ulcers
por: Yonan, Yousif A., et al.
Publicado: (2019) -
A Case of Folliculotropic Mycosis Fungoides Complicated by Granulomatous Mycosis Fungoides
por: Li, Hongda, et al.
Publicado: (2023) -
Folliculotropic Mycosis Fungoides
por: Tambe, Swagata A., et al.
Publicado: (2021)